应用即用型多分支内移植物紧急血管内修复近肾/肾周动脉瘤
这项观察性多中心回顾性研究分析了2013至2023年间23个欧洲主动脉中心使用即用型多分支胸腹主动脉内移植物(Cook T-branch)紧急修复近肾/肾周动脉瘤的197例患者,技术成功率92%,30天/住院死亡率11%,但脊髓缺血发生率达8%,尤其在破裂或需附加近端胸主动脉内移植物时更高。
要点
- 紧急T-branch修复近肾/肾周动脉瘤技术成功率92%,30天/住院死亡率11%。
- 破裂是技术失败(OR 3.8)和脊髓缺血(OR 3.1)的危险因素。
- 附加近端胸主动脉内移植物增加脊髓缺血风险(OR 4.1)。
核心结论
- T-branch紧急修复近肾/肾周动脉瘤在高危患者中可行且有效,技术成功率和30天/住院死亡率可接受。
- 但需要广泛的主动脉覆盖,导致不可忽视的脊髓缺血率,尤其在主动脉破裂或需附加胸主动脉内移植物时。
- 既往EVAR失败、术后肠系膜并发症以及心脏和呼吸系统并发症与30天/住院死亡率相关,应进一步研究以改善 outcomes。
研究设计与样本
- 观察性、多中心、回顾性研究,纳入2013至2023年23个欧洲主动脉中心接受T-branch紧急血管内修复的近肾/肾周动脉瘤患者197例,其中近肾动脉瘤64例(33%)、肾周动脉瘤95例(48%)、既往EVAR失败38例(19%)。
- 紧急修复指征为包含性近肾/肾周动脉瘤破裂、存在相关症状、动脉瘤直径>70 mm。
主要发现
- 平均年龄75±8岁,平均动脉瘤直径76±4 mm,ASA评分3分118例(60%)、4分79例(40%)。
- 破裂、症状、直径>70 mm分别见于51例(26%)、110例(56%)、53例(27%)。
- 技术成功182例(92%)(破裂组84% vs 无破裂组95%;P = .02)。
- 持续性脊髓缺血15例(8%)(破裂组14% vs 无破裂组5%),截瘫11例(6%)(破裂组10% vs 无破裂组5%;P = .001)。
- 30天或延长住院期间死亡22例(11%);平均随访19±5个月,估计3年生存率58%,免于再干预率77%,目标动脉不稳定27例(14%)(闭塞15例、内漏14例),估计3年免于目标动脉不稳定率72%。
关键数值与推荐
- 破裂是技术失败的危险因素(P = .02;OR 3.8;95%CI 1.1-12.1)。
- 破裂(P = .04;OR 3.1;95%CI 1.1-8.9)和附加近端胸主动脉内移植物(P = .01;OR 4.1;95%CI 1.3-12.9)是脊髓缺血的危险因素。
- 既往EVAR失败(P = .04;OR 3.6;95%CI 1.1-12.3)、截瘫(P < .001;OR 9.9;95%CI 1.6-62.2)、术后肠系膜并发症(P = .03;OR 10.4;95%CI 1.2-93.3)、心脏并发症(P = .03;OR 8.2;95%CI 2.0-33.0)和呼吸系统并发症(P < .001;OR 10.1;95%CI 2.9-35.2)与30天/住院死亡率相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report outcomes of urgent juxtarenal/pararenal aneurysms (J/P-AAAs) managed by off-the-shelf multibranched thoracoabdominal endografts (Cook, T-branch). METHODS: In this observational, multicenter, retrospective study, patients with J/P-AAAs treated by urgent endovascular repair by T-branch in 23 European aortic centers, from 2013 to 2023, were analyzed. Contained J/P-AAAs rupture, presence of related symptoms, and aneurysm diameter of >70 mm were considered as indication for urgent repair. Technical success (TS), spinal cord ischemia (SCI), and 30-day/hospital mortality were assessed as early outcomes. Survival, freedom from reinterventions, and target artery instability (TAI) were evaluated during follow-up. RESULTS: Overall, 197 patients (J-AAAs, n = 64 [33%]; P-AAAs, n = 95 [48%]; previous failed endovascular aneurysm repair (EVAR), n = 38 [19%]) were analyzed. The mean age and aneurysm diameter was 75 ± 8 years and 76 ± 4 mm, respectively. The American Society of Anesthesiologists score was 3 and 4 in 118 (60%) and 79 (40%) patients. Rupture, symptoms, and diameter of >70 mm were present in 51 (26%), 110 (56%), and 53 (27%) patients, respectively. An adjunctive proximal thoracic endograft was used in 28 cases (14%). The mean aortic coverage between the upper portion of the endograft and the lowest renal artery was 154 ± 49 mm. Single-stage repair and cerebrospinal fluid drainage were reported in 144 (73%) and 53 (27%) cases, respectively. TS was achieved in 182 (92%) cases (rupture, 84% vs no rupture, 95%; P = .02). Failures consist of TA loss (11 [6%]: renal artery, 9; celiac trunk, 2), type I to III endoleaks (2 [1%]), and 24-h mortality (2 [1%]). Rupture was a risk factor for technical failure (P = .02; odds ratio [OR], 3.8; 95% confidence interval [CI], 1.1-12.1). Overall, 15 patients (8%) had persistent SCI (rupture, 14% vs no rupture, 5%) with 11 (6%) , of paraplegia (rupture, 10% vs no rupture, 5%; P = .001). Rupture (P = .04; OR, 3.1; 95% CI, 1.1-8.9) and adjunctive proximal thoracic endograft (P = .01; OR, 4.1; 95% CI, 1.3-12.9) were risk-factors for SCI. Twenty-two patients (11%) died within 30 days or during a prolonged hospitalization. Previous failed EVAR (P = .04; OR, 3.6; 95% CI, 1.1-12.3), paraplegia (P < .001; OR, 9.9; 95% CI, 1.6-62.2) and postoperative mesenteric complications (P = .03; OR, 10.4; 95% CI, 1.2-93.3), as well as cardiac (P = .03; OR, 8.2; 95% CI, 2.0-33.0) and respiratory (P < .001; OR, 10.1; 95% CI, 2.9-35.2) morbidities were associated with 30-day/hospital mortality. The mean follow-up was 19 ± 5 months. The estimated 3-year survival and freedom from reinterventions was 58% and 77%, respectively. TAI occurred in 27 patients (14%) (occlusion, 15; endoleak, 14) with an estimated 3-year freedom from TAI of 72%. CONCLUSIONS: Urgent repair of J/P-AAAs by T-branch is feasible and effective with satisfactory TS and 30-day/hospital mortality in high-risk patients. However, extensive aortic coverage is necessary, leading to a non-negligible SCI rate, especially in case of aortic rupture or when adjunctive thoracic endografts are necessary. Previous failed EVAR and postoperative mesenteric complications, as well as cardiac and respiratory morbidities were associated with 30-day/hospital mortality and should be subjected to more research for the purposes of improving outcomes.
引用
- Gallitto E, Faggioli G, Austermann M, et al. Urgent endovascular repair of juxtarenal/pararenal aneurysm by off-the-shelf multibranched endograft. J Vasc Surg. 2024. PMID: 38992807. doi:10.1016/j.jvs.2024.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。